Product Information
TREXALL 7.5 MG TABLET is a brand (anda) product labeled by Teva Women's Health, Inc., priced at $36.2091 per EA under NDC 51285036701. Its NADAC has been published 19 times since Feb 18, 2026.
The High Outlier badge above means this manufacturer's average price in the Methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.5 mg/1
Manufacturer
Teva Women's Health, Inc.NDC
51285036701
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040385On Market Since
5/3/2001
Pharmacological Classes
Price Statistics
The NADAC for TREXALL 7.5 MG TABLET has been published 19 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.2091 per EA |
|---|---|
| All-time high | $36.2091 (Jun 24, 2026) |
| All-time low | $36.2091 (Feb 18, 2026) |
| 52-week high | $36.2091 |
| 52-week low | $36.2091 |
| Median price | $36.2091 |
| Average price | $36.2091 |
| Largest weekly change | 0.0% (Feb 25, 2026) |
| Weeks tracked | 19 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methotrexate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TREXALL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TREXALL 7.5 MG TABLET, manufactured by Teva Women's Health, Inc., is $36.2091 per EA (NDC 51285036701), effective Jun 24, 2026.
How has the price of TREXALL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TREXALL 7.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 19 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for TREXALL 7.5 MG TABLET?
Since Feb 18, 2026, the NADAC for TREXALL 7.5 MG TABLET has ranged from a low of $36.2091 (Feb 18, 2026) to a high of $36.2091 (Jun 24, 2026), with a median of $36.2091 per EA.
Are there cheaper alternatives to TREXALL 7.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TREXALL 7.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TREXALL 7.5 MG TABLET?
TREXALL 7.5 MG TABLET (NDC 51285036701) is labeled by Teva Women's Health, Inc., and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification